TDL INNOVATIONS LLC

Princeton, NJ · Medtech · Private

Foam-based sclerosing agent delivery system for treating malignant pleural effusions

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Princeton, NJ
Total capital: $4.4M

Federal grants: $4.4M; 6 awards · 2017–2021; Rank in peer group#491 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 6; 11 pending · first 2018; Rank in peer group#97 of 538

Capital timeline

Latest events

Jun 2021Federal grantHealth and Human S · Phase II · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.$199K
Feb 2020Federal grantHealth and Human S · Phase II · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.$960K
Mar 2019Federal grantHealth and Human S · Phase II · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.$1.9M
Mar 2019Federal grantHealth and Human S · Phase II · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.$930K
Sep 2017Federal grantHealth and Human S · Phase I · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion$225K
Aug 2017Federal grantHealth and Human S · Phase I · An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#97 · top 18%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 6 granted of 17

Nov 25, 2025GrantedMethods and Devices for Removing a Tissue Specimen from a PatientUSPTOUS 12,478,361
Oct 31, 2024PendingFoam Compositions For Treating Clostridioides Difficile InfectionsUSPTOApplication 18556444
Aug 20, 2024GrantedMedical Foam for Delivery of an Active AgentUSPTOUS 12,064,510

Show all 17 patent records

Methods and Devices for Removing a Tissue Specimen from a PatientNov 25, 2025 · US 12,478,361Granted
Foam Compositions For Treating Clostridioides Difficile InfectionsOct 31, 2024 · Application 18556444Pending
Medical Foam for Delivery of an Active AgentAug 20, 2024 · US 12,064,510Granted
Methods and Devices for Removing a Tissue Specimen from a PatientJun 27, 2023 · US 11,684,351Granted
Foam Compositions For The Treatment Of CancerMar 2, 2023 · Application 17760073Pending
Methods and Compositions for Administering an Active Agent to the Pleura of a PatientNov 18, 2021 · Application 17113607Pending
Methods and Compositions for Administering an Active Agent to the Pleura of a PatientDec 8, 2020 · US 10,857,100Granted
Methods and Devices for Removing a Tissue Specimen from a PatientAug 4, 2020 · US 10,729,414Granted
Methods and Compositions for Administering an Active Agent to the Pleura of a PatientOct 30, 2018 · US 10,111,834Granted
Steerable Aspiration Catheter SystemFeb 16, 2017 · Application 15233870Pending
Methods And Divices For Removing A Tissue Specimen From A PatientApplication PCTUS2017024887Pending
Foam Compositions For The Treatment Of CancerApplication PCTUS2021016487Pending
Foam Compositions for Treating Clostridioides Difficile InfectionsApplication 63178234Pending
Steerable Aspiration Catheter SystemApplication PCTUS2016046431Pending
Methods And Compositions For Administering An Active Agent To The Pleura Of A PatientApplication PCTUS2015023468Pending
Foam Compositions For The Treatment Of CancerApplication 62969493Pending
Foam Compositions For Treating Clostridioides Difficile InfectionsApplication PCTUS2022025934Pending

RADIATION DETECTION & IMAGING TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
Nuclein, LLCSimilar federal contract value in Medtech · null in contracts
Medality Medical, LLCSimilar federal contract value in Medtech · null in contracts
KoKo Medical, Inc.Similar federal contract value in Medtech · null in contracts
XpandOrtho, IncSimilar federal contract value in Medtech · null in contracts
SAGESPECTRA INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.